本頁面由Tiger Trade Technology Pte. Ltd.提供服務

AN2 Therapeutics, Inc.

5.41
-0.2800-4.92%
盤後5.410.00000.00%19:30 EDT
成交量:10.35萬
成交額:56.93萬
市值:2.04億
市盈率:-5.20
高:5.78
開:5.70
低:5.40
收:5.69
52周最高:7.19
52周最低:1.00
股本:3,773.62萬
流通股本:2,140.93萬
量比:0.51
換手率:0.48%
股息:- -
股息率:- -
每股收益(TTM):-1.0401
每股收益(LYR):-1.1641
淨資產收益率:-50.12%
總資產收益率:-30.80%
市淨率:2.69
市盈率(LYR):-4.65

資料載入中...

2024/08/13

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report
2024/08/12

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/08/08

重要事件披露

Form 8-K - Current report
2024/07/03

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/06/25

重要事件披露

Form 8-K - Current report
2024/05/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/14

重要事件披露

Form 8-K - Current report
2024/05/14

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/04/10

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/29

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/29

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/28

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/12

重要事件披露

Form 8-K - Current report
2024/02/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]